Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
9,633,125
-
Shares change
-
+925,753
-
Total reported value, excl. options
-
$883,813,866
-
Value change
-
+$85,577,040
-
Put/Call ratio
-
170%
-
Number of buys
-
54
-
Number of sells
-
-38
-
Price
-
$91.78
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q3 2014
107 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q3 2014.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,633,125 shares
.
Largest 10 shareholders include MORGAN STANLEY (2,233,456 shares), WELLS FARGO & COMPANY/MN (1,689,827 shares), FIRST TRUST ADVISORS LP (1,454,495 shares), UBS AG (725,782 shares), BANK OF AMERICA CORP /DE/ (668,625 shares), RAYMOND JAMES & ASSOCIATES (348,556 shares), GOLDMAN SACHS GROUP INC (300,230 shares), ROYAL BANK OF CANADA (231,773 shares), LPL Financial LLC (227,470 shares), and RiverFront Investment Group, LLC (140,347 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.